Results 1 to 10 of about 1,500,169 (183)

Aripiprazole-induced liver injury: a spontaneous reporting database study [PDF]

open access: yesFrontiers in Pharmacology, 2023
Background: There have been individual case reports of aripiprazole in recent years, both domestically and internationally, but no analysis of the characteristics of the occurrence of adverse reactions/events of drug-induced liver injury with ...
Yunjuan Gao   +11 more
doaj   +2 more sources

Active monitoring vs. spontaneous reporting of antineoplastic drug–related adverse drug reactions: evidence from the Chinese hospital pharmacovigilance system [PDF]

open access: yesFrontiers in Health Services
BackgroundAdverse drug reactions (ADRs) remain a major barrier to safe and effective cancer therapy. Existing pharmacovigilance systems predominantly rely on spontaneous reporting, which suffers from underreporting and delays.
Hao Jing   +9 more
doaj   +2 more sources

A South Indian Journey on the Trivialized Healthcare Menace of Adverse Drug Reactions [PDF]

open access: yesPatient Safety and Quality Improvement Journal, 2023
Introduction:The primary objective is to encourage HCPs to report more ADRs by bringing out data on the incidence, rate and characteristics of ADRs, ADR-related hospital admissions and by exposing their impact on patient outcomes.Materials and Methods ...
Aneesha PK   +3 more
doaj   +1 more source

Parental reporting of adverse drug reactions in South Africa: An online survey

open access: yesAfrican Journal of Primary Health Care & Family Medicine, 2021
Background: The high incidence of adverse drug reactions (ADRs) in children is of global concern. Enhancing the reporting of ADRs could contribute to making safer medicines available to children.
Shavani Pillay   +2 more
doaj   +1 more source

Spontaneous reporting of adverse drug reaction among health professionals in Ghana

open access: yesArchives of Public Health, 2022
Background Spontaneous reporting of adverse drug reactions (ADR) is an effective means of ensuring postmarketing surveillance of drugs, and health professionals play a cardinal role through voluntary reporting of ADR.
Morrison Asiamah   +4 more
doaj   +1 more source

Spontaneous reporting of adverse drug reactions: nurses’ perception [PDF]

open access: yesE3S Web of Conferences, 2021
Introduction: Spontaneous reporting of adverse drug reactions is the basis of pharmacovigilance, the main objective of which is to ensure the safe use of drugs, particularly cytotoxics, through continuous monitoring of adverse events caused by them.
Erefai Ouassima   +4 more
doaj   +1 more source

Adverse events following immunization associated with coronavirus disease 2019 (COVID-19) vaccines: A descriptive analysis from VigiAccess

open access: yesHuman Vaccines & Immunotherapeutics, 2022
This study assessed adverse events following immunizations (AEFIs) reported on COVID-19 vaccines in VigiAccess and determined the reporting trends across all continents of the world. The study was cross-sectional quantitative in design.
Peter Yamoah   +5 more
doaj   +1 more source

Structure of Adverse Events Following Immunisation against Coronavirus Infection (COVID-19) in the Kyrgyz Republic

open access: yesБезопасность и риск фармакотерапии, 2022
There is considerable interest worldwide in developing safe and effective vaccines against COVID-19. Pharma-covigilance of adverse events following immunisation (AEFIs) is a key to making informed decisions regarding the global COVID-19 vaccination ...
A. A. Zurdinova   +3 more
doaj   +1 more source

Spontaneous Reports of Serious Adverse Drug Reactions Resulting From Drug–Drug Interactions: An Analysis From the French Pharmacovigilance Database

open access: yesFrontiers in Pharmacology, 2021
Few data are available on the clinical impact of drug–drug interactions (DDIs). Most of the studies are limited to the analysis of exposure to potential DDI or the targeted impact of the combination of a few drugs or therapeutic classes.
Louis Létinier   +11 more
doaj   +1 more source

Advances in Pharmacovigilance in India: Role of Mobile Application

open access: yesIndian Journal of Medical Specialities, 2020
India is the fourth largest manufacturer and the second largest consumer of pharmaceuticals in the world. Hospitalizations due to adverse drug reactions (ADRs) lead to a considerable burden on the health-care system and economy of the country ...
Rajpushpa Labh   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy